tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
IMAB is currently covered by 4 analysts with an average price target of $13.82. This is a potential upside of $12.97 (1525.88%) from yesterday's end of day stock price of $0.85.
I-Mab's activity chart (see below) currently has 15 price targets and 29 ratings on display. The stock rating distribution of IMAB is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 28.57% with an average time for these price targets to be met of 77.25 days.
Highest price target for IMAB is $8, Lowest price target is $8, average price target is $7.
Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 15-Nov-2024. First documented stock forecast 27-Jul-2020.
Currently out of the existing stock ratings of IMAB, 15 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$8
$6.98 (684.31%)
$8
5 months 9 days ago
(15-Nov-2024)
1/7 (14.29%)
$6.97 (676.70%)
85
Buy
$6
$4.98 (488.24%)
$8
1 years 12 days ago
(12-Apr-2024)
0/4 (0%)
$4.19 (231.49%)
Buy
1 years 7 months 19 days ago
(05-Sep-2023)
3/4 (75%)
$13.97 (18.37%)
133
Buy
$35
2 years 21 days ago
(03-Apr-2023)
1/4 (25%)
$26.73 (323.22%)
91
What is IMAB (I-Mab) average time for price targets to be met?
Which analyst has the current highest performing score on IMAB (I-Mab) with a proven track record?
Which analyst has the current lower performing score on IMAB (I-Mab) with a proven track record?
Which analyst has the most public recommendations on IMAB (I-Mab)?
Which analyst is the currently most bullish on IMAB (I-Mab)?
Which analyst is the currently most reserved on IMAB (I-Mab)?
